| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 110 |
| 1 | PREDNISONE | 109 |
| 2 | RITUXIMAB | 59 |
| 3 | CAPECITABINE | 53 |
| 4 | CYCLOPHOSPHAMIDE | 48 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 48 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 48 |
| 7 | IBRUTINIB | 46 |
| 8 | METHOTREXATE SODIUM | 46 |
| 9 | ACETAMINOPHEN | 45 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPINEPHRINE HYDROCHLORIDE | 9 | 0.0190 |
| 1 | TETRAHYDROZOLINE HYDROCHLORIDE | 5 | 0.0170 |
| 2 | ALUMINUM HYDROXIDE GEL | 2 | 0.0136 |
| 3 | PAROMOMYCIN SULFATE | 1 | 0.0094 |
| 4 | MINERAL OIL | 8 | 0.0054 |
| 5 | FUTIBATINIB | 1 | 0.0045 |
| 6 | CAMPHOR, EUCALYPTUS OIL, MENTHOL | 1 | 0.0043 |
| 7 | FIRST AID ANTIBIOTIC | 1 | 0.0042 |
| 8 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE | 1 | 0.0042 |
| 9 | FEXOFENADINE HYDROCHLORIDE TABLETS | 1 | 0.0039 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 186 |
| 1 | Kinase Inhibitor [EPC] | 135 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 74 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 73 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 65 |
| 5 | Alkylating Drug [EPC] | 63 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 62 |
| 7 | Platinum-based Drug [EPC] | 55 |
| 8 | Proton Pump Inhibitor [EPC] | 49 |
| 9 | Integrin Receptor Antagonist [EPC] | 46 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Anthelmintic [EPC] | 7 | 0.0024 |
| 2 | Rifamycin Antimycobacterial [EPC] | 7 | 0.0020 |
| 3 | Provitamin D2 Compound [EPC] | 31 | 0.0010 |
| 4 | CD30-directed Immunoconjugate [EPC] | 9 | 0.0009 |
| 5 | Enzyme Stabilizer [EPC] | 1 | 0.0009 |
| 6 | Estrogen Receptor Antagonist [EPC] | 33 | 0.0008 |
| 7 | Pyruvate Kinase Activator [EPC] | 1 | 0.0008 |
| 8 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 5 | 0.0007 |
| 9 | Anti-coagulant [EPC] | 2 | 0.0005 |